Copyright
©The Author(s) 2017.
World J Orthop. Jan 18, 2017; 8(1): 62-67
Published online Jan 18, 2017. doi: 10.5312/wjo.v8.i1.62
Published online Jan 18, 2017. doi: 10.5312/wjo.v8.i1.62
Table 3 Univariable and multivariate analysis with linear regression of association between risk factors for the total blood loss in the 74 patients
| Univariable estimate (95%CI) | P value | Multivariable estimate (95%CI) | P value | |
| Tourniquet (used) | -39 (-370-293) | 0.810 | -78 (-431-275) | 0.659 |
| Age (per year older) | -10 (-25-5) | 0.210 | -7 (-23-9) | 0.384 |
| Women/men (men) | 320 (-22-662) | 0.066 | 221 (-149-590) | 0.237 |
| Specialist registrar/consultant (consultant) | -335 (-676-6) | 0.054 | -324 (-689-41) | 0.081 |
| Clopidogrel (in treatment) | 33 (-390-456) | 0.876 | -86 (-520-349) | 0.696 |
| NSAID/acetylsalicylic acid (in treatment) | 205 (-124-534) | 0.218 | 223 (-126-572) | 0.206 |
| Duration of surgery (per minute) | 1 (-5-7) | 0.752 | -3 (-10-5) | 0.482 |
| ASA-1-2/ASA 3-4 (ASA 3-4) | -1 (424-422) | 0.995 | -66 (-506-373) | 0.764 |
| Body mass index (per one unit) | 21 (-9-52) | 0.162 | 17 (-17-50) | 0.322 |
- Citation: Wied C, Tengberg PT, Holm G, Kallemose T, Foss NB, Troelsen A, Kristensen MT. Tourniquets do not increase the total blood loss or re-amputation risk in transtibial amputations. World J Orthop 2017; 8(1): 62-67
- URL: https://www.wjgnet.com/2218-5836/full/v8/i1/62.htm
- DOI: https://dx.doi.org/10.5312/wjo.v8.i1.62